Open AccessIs Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
Author(s) -
Vishal Hegde,
Zachary Burke,
Howard Y. Park,
Stephen D. Zoller,
Daniel Johansen,
Benjamin Kelley,
Ben Levine,
Kambiz Motamedi,
Noah Federman,
Leanne L. Seeger,
Scott D. Nelson,
Nicholas M. Bernthal
Publication year - 2018
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1007/s11999.0000000000000062
Subject(s) - medicine , malignancy , biopsy , radiology , aneurysmal bone cyst , osteosarcoma , bone pathology , medical diagnosis , surgical pathology , surgery , pathology , lesion
Although there is widespread acceptance of core needle biopsy (CNB) for diagnosing solid tumors, there is reluctance by some clinicians to use CNB for aneurysmal bone cysts (ABCs) as a result of concerns of safety (bleeding, nerve injury, fracture, readmission, or infection) and reliability, particularly to rule out malignant diagnoses like telangiectatic osteosarcoma. This is especially true when CNB tissue is sent from an outside hospital, where the technique used to obtain the tissue may be spurious.